Recommendations issued to prevent VTE in maternal patients

December 11, 2013
Recommendations issued to prevent VTE in maternal patients

(HealthDay)—The Physician-Patient Alliance for Health & Safety, the Institute for Healthcare Improvement, and the National Perinatal Association have developed safety recommendations aimed at preventing venous thromboembolism (VTE) in maternal patients.

A panel of experts, brought together by the Patient-Physician Alliance for Health & Safety, developed VTE safety recommendations for prevention of VTE.

The safety recommendations include four steps: (1) patients should be evaluated for VTE risk using an easy-to-use automated scoring system; (2) depending on whether the mother is antepartum or postpartum, the recommended prophylaxis regimen should be provided; (3) the patient should be reassessed every 24 hours or upon occurrence of a significant event such as surgery; and (4) upon hospital discharge, the mother should be provided with appropriate VTE prevention education.

"The risks of VTE are four to five times higher for pregnant than for non-pregnant women," MaryAnne Laffin, N.P., immediate past president of the National Perinatal Association, said in a statement. "For the safety of pregnant women, the National Perinatal Association therefore encourages all hospitals to adopt these VTE safety recommendations."

Explore further: Study finds high clot risk for women admitted to hospital during pregnancy

More information: More Information

Related Stories

Post-op prophylactic heparin poses very low bleed risk

November 11, 2013

(HealthDay)—The risk of hemorrhage seems to be very low when prophylactic low-molecular-weight heparin (LMWH) is initiated 24 to 36 hours after degenerative spine surgery but the associated venous thromboembolism (VTE) ...

VTE occurs in 13 percent of head, neck cancer surgery cases

October 4, 2013

(HealthDay)—Venous thromboembolism (VTE) rates in a prospective cohort of head and neck cancer surgical patients are higher than previously reported in retrospective studies, according to research published online Sept. ...

VTE risk varies by hormone therapy formulation

September 18, 2012

(HealthDay)—The risk of venous thromboembolism (VTE) in postmenopausal women differs considerably according to the formulation of hormone therapy (HT) used, with the highest VTE risk seen in users of oral estrogen-progestin ...

Recommended for you

Zika virus infection alters human and viral RNA

October 20, 2016

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Neurodevelopmental model of Zika may provide rapid answers

October 19, 2016

A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a ...

Scientists uncover new facets of Zika-related birth defects

October 17, 2016

In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.